Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XENE

Xenon Pharmaceuticals Inc

May 29 • 04:00PM ET

54.73

-0.06 -0.11 %

Healthcare • Biotechnology • Canada • Mid • NASD

Peers: ACAD AXSM INCY NBIX BMRN VKTX MDGL ALKS KROS BIIB

| Held by: IWM IWO IBB VTWO SPDW SBIO VTWG NUSC VT FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.70	Insider Own	6.16%	Shs Outstand	96.62M	Perf Week	1.13%
Market Cap	5.29B	Forward P/E	-	EPS next Y	-4.93	Insider Trans	-5.73%	Shs Float	90.72M	Perf Month	-1.83%
Enterprise Value	4.20B	PEG	-	EPS next Q	-1.15	Inst Own	98.68%	Short Float	4.23%	Perf Quarter	26.60%
Income	-383.17M	P/S	-	EPS this Y	-9.61%	Inst Trans	19.38%	Short Ratio	2.60	Perf Half Y	24.56%
Sales	0.00M	P/B	3.95	EPS next Y	-3.23%	ROA	-35.98%	Short Interest	3.83M	Perf YTD	22.11%
Book/sh	13.85	P/C	4.83	EPS next 5Y	10.72%	ROE	-37.53%	52W High	63.95 -14.42%	Perf Year	88.46%
Cash/sh	11.33	P/FCF	-	EPS past 3/5Y	-28.36% -40.02%	ROIC	-28.51%	52W Low	28.19 94.15%	Perf 3Y	36.52%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-7.36% -25.26%	Gross Margin	-	Volatility	2.65% 2.96%	Perf 5Y	196.32%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-46.29%	Oper. Margin	-	ATR (14)	1.69	Perf 10Y	735.57%
Dividend Ex-Date	-	Quick Ratio	27.79	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	47.57	Recom	1.05
Dividend Gr. 3/5Y	- -	Current Ratio	27.79	EPS Q/Q	-41.69%	SMA20	-1.16%	Beta	0.63	Target Price	80.56
Payout	-	Debt/Eq	0.01	Sales Q/Q	-100.00%	SMA50	-2.39%	Rel Volume	0.93	Prev Close	54.79
Employees	370	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	20.39%	Avg Volume	1.47M	Price	54.73
IPO	Nov 05, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.81% -100.00%	Trades		Volume	1,374,804	Change	-0.11%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)